The post Bitcoin Price Crash Could Deepen, Peter Schiff Warns appeared first on Coinpedia Fintech News Bitcoin price today is trading in the $85,000–$86,000 rangeThe post Bitcoin Price Crash Could Deepen, Peter Schiff Warns appeared first on Coinpedia Fintech News Bitcoin price today is trading in the $85,000–$86,000 range

Bitcoin Price Crash Could Deepen, Peter Schiff Warns

2025/12/17 15:12
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]
Bitcoin Price Crash

The post Bitcoin Price Crash Could Deepen, Peter Schiff Warns appeared first on Coinpedia Fintech News

Bitcoin price today is trading in the $85,000–$86,000 range at press time, pulling back sharply from recent highs. The price currently sits near $85,654, down around 4%–7% in the past 24 hours. Earlier in the session, Bitcoin briefly climbed close to $89,948 before reversing, underlining the increase in short-term volatility.

As prices cool, long-time Bitcoin critic Peter Schiff has renewed crash warnings. He points to the strong rally in gold and silver as a sign that investors may be shifting capital away from risk assets like Bitcoin and back into traditional safe havens. According to Schiff, fading confidence across markets could leave Bitcoin vulnerable to deeper losses.

Schiff Challenges Bitcoin’s Safe-Haven Narrative

Schiff argues that many investors bought Bitcoin as protection against a weakening U.S. dollar. However, he believes that the argument is losing strength. With gold and silver hitting record highs, Schiff says investors are clearly placing more trust in precious metals during periods of uncertainty. In his view, if market fear intensifies, Bitcoin may face selling pressure instead of acting as a hedge.

He also warns that those expecting Bitcoin to protect their portfolios during economic stress could be caught off guard if prices continue to fall.

Precious Metals Send a Strong Signal

The surge in precious metals has been hard to ignore. Silver jumped more than $1.60 in a single session, pushing above $66, while gold climbed past $4,300 to fresh highs. Schiff believes silver could approach $70 by year-end, with gold moving even higher.

He sees this move as a sign of weakening confidence in the U.S. dollar and government bonds. Rising metal prices, according to Schiff, reflect growing concern about the economy and the stability of the financial system.

What’s Driving the Concern?

Schiff believes the U.S. economy is moving toward serious trouble, citing risks such as persistent inflation, rising unemployment, and declining trust in financial institutions. In that environment, he argues Bitcoin may struggle rather than benefit, especially if investors rush to cut risk.

Other analysts echo similar caution. Bloomberg Intelligence strategist Mike McGlone has suggested Bitcoin could fall further if demand continues to weaken. Meanwhile, 10x Research has warned that $10–$20 billion in crypto hedge fund redemptions could add selling pressure toward the end of the year.

Bitcoin Holders Push Back

Despite the warnings, much of the Bitcoin community remains unconvinced. Long-term holders point out that Bitcoin has survived multiple drawdowns of more than 80% and has still gone on to reach new highs. Many brushed off Schiff’s comments, noting he has predicted Bitcoin’s collapse since it traded near $100.

Others argue Bitcoin doesn’t behave like a typical risk asset. While it often sells off during early market shocks, supporters say it can diverge during deeper confidence crises. In their view, gold preserves wealth within the financial system, while Bitcoin offers mobility and an exit from it, keeping long-term conviction intact despite short-term volatility.

Market Opportunity
NEAR Logo
NEAR Price(NEAR)
$1.2186
$1.2186$1.2186
-0.95%
USD
NEAR (NEAR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09